Cargando…
Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713954/ http://dx.doi.org/10.1007/s12325-014-0118-8 |
_version_ | 1782410231024713728 |
---|---|
author | Costabel, Ulrich Bendstrup, Elisabeth Cottin, Vincent Dewint, Pieter Egan, Jim J. J. Ferguson, James Groves, Richard Hellström, Per M. Kreuter, Michael Maher, Toby M. Molina-Molina, Maria Nordlind, Klas Sarafidis, Alexandre Vancheri, Carlo |
author_facet | Costabel, Ulrich Bendstrup, Elisabeth Cottin, Vincent Dewint, Pieter Egan, Jim J. J. Ferguson, James Groves, Richard Hellström, Per M. Kreuter, Michael Maher, Toby M. Molina-Molina, Maria Nordlind, Klas Sarafidis, Alexandre Vancheri, Carlo |
author_sort | Costabel, Ulrich |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4713954 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-47139542016-01-21 Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events Costabel, Ulrich Bendstrup, Elisabeth Cottin, Vincent Dewint, Pieter Egan, Jim J. J. Ferguson, James Groves, Richard Hellström, Per M. Kreuter, Michael Maher, Toby M. Molina-Molina, Maria Nordlind, Klas Sarafidis, Alexandre Vancheri, Carlo Adv Ther Erratum Springer Healthcare 2014-05-08 2014 /pmc/articles/PMC4713954/ http://dx.doi.org/10.1007/s12325-014-0118-8 Text en © Springer Healthcare 2014 |
spellingShingle | Erratum Costabel, Ulrich Bendstrup, Elisabeth Cottin, Vincent Dewint, Pieter Egan, Jim J. J. Ferguson, James Groves, Richard Hellström, Per M. Kreuter, Michael Maher, Toby M. Molina-Molina, Maria Nordlind, Klas Sarafidis, Alexandre Vancheri, Carlo Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events |
title | Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events |
title_full | Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events |
title_fullStr | Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events |
title_full_unstemmed | Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events |
title_short | Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events |
title_sort | erratum to: pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713954/ http://dx.doi.org/10.1007/s12325-014-0118-8 |
work_keys_str_mv | AT costabelulrich erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents AT bendstrupelisabeth erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents AT cottinvincent erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents AT dewintpieter erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents AT eganjimjj erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents AT fergusonjames erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents AT grovesrichard erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents AT hellstromperm erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents AT kreutermichael erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents AT mahertobym erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents AT molinamolinamaria erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents AT nordlindklas erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents AT sarafidisalexandre erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents AT vanchericarlo erratumtopirfenidoneinidiopathicpulmonaryfibrosisexpertpaneldiscussiononthemanagementofdrugrelatedadverseevents |